The number of diagnosed cases is expected to rise to 3.1 million. The Parkinson’s disease (PD) market across the seven major ...

WEDNESDAY, Feb. 5, 2025 (HealthDay News) -- Hopes that GLP-1 drugs such as Ozempic and Wegovy could help slow Parkinson's ...

Treatment with exenatide, a GLP-1 receptor agonist, was comparable to placebo in slowing the rate of Parkinson’s disease ...

The FDA approved an apomorphine hydrochloride infusion device (Onapgo) to treat motor fluctuations in adults with advanced ...

The U.S. Food and Drug Administration has approved Supernus Pharmaceuticals' drug-device combination to treat ...

Traditional deep brain stimulation surgery can take up to 10 hours to complete, with the patient wide awake. This robotic ...

OZZY OSBOURNE will call it a day in true rock-god style with a final blow-out hailed as “the greatest heavy metal show ever”.

The FDA on Tuesday signed off on Supernus Pharmaceuticals’ apomorphine hydrochloride injection—to be marketed under the brand ...

Three strikes and you’re out? Not for Supernus Pharmaceuticals and its Parkinson’s disease infusion pump. | The device is ...

The FDA has approved the first and only subcutaneous apomorphine infusion device, apomorphine hydrochloride injection (Onapgo ...

The singer-songwriter gained recognition from the Recording Academy in the early 1990s, winning the Grammy for Best New ...

Sharon Osbourne has revealed her husband Ozzy can no longer walk due to Parkinson's disease. The Brummie rock star is set to ...